Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 2/20 | 0.50 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.50 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.50 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.45 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | DRD2 | P14416 | 3/20 | 0.45 |
| ▸ | DRD3 | P35462 | 3/20 | 0.45 |
| ▸ | DRD4 | P21917 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7932817 | 1.00 | CHRM2 (0.50) | CHRM2CHRM1CHRM3MTNR1AMTNR1B | |
| SCHEMBL7932813 | 1.00 | CHRM2 (0.50) | CHRM2CHRM1CHRM3MTNR1AMTNR1B | |
| SCHEMBL8676617 | 1.00 | CHRM2 (0.50) | CHRM2CHRM1CHRM3MTNR1AMTNR1B | |
| Hydrochloric Acid SCHEMBL7932910 | 0.85 | CHRM2 (0.51) | CHRM2CHRM1CHRM3MTNR1AMTNR1B | |
| Hydrochloric Acid SCHEMBL7932906 | 0.85 | CHRM2 (0.51) | CHRM2CHRM1CHRM3MTNR1AMTNR1B | |
| Hydrochloric Acid SCHEMBL7935305 | 0.85 | CHRM2 (0.51) | CHRM2CHRM1CHRM3MTNR1AMTNR1B | |
| Hydrochloric Acid SCHEMBL9018570 | 0.85 | CHRM2 (0.51) | CHRM2CHRM1CHRM3MTNR1AMTNR1B | |
| SCHEMBL20460429 | 0.84 | CHRM2 (0.52) | CHRM2CHRM1CHRM3MTNR1AMTNR1B | |
| SCHEMBL4215401 | 0.81 | CHRM2 (0.55) | CHRM2CHRM1CHRM3MTNR1AMTNR1B | |
| SCHEMBL9727207 | 0.81 | CHRM2 (0.55) | CHRM2CHRM1CHRM3MTNR1AMTNR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2785879-B2 | — | — | 1998-08-13 | — | — | JP | claimed |
| WO-1992006967-A1 | THERAPEUTICALLY USEFUL 2-AMINOTETRALIN DERIVATIVES | THE UPJOHN COMPANY (US) | 1992-04-30 | — | — | WO | claimed |
| EP-0476016-A1 | THERAPEUTICALLY USEFUL 2-AMINOTETRALIN DERIVATIVES | PHARMACIA & UPJOHN COMPANY (US) | 1992-03-25 | — | — | EP | claimed |
| WO-1990015047-A1 | THERAPEUTICALLY USEFUL 2-AMINOTETRALIN DERIVATIVES | THE UPJOHN COMPANY (US) | 1990-12-13 | — | — | WO | claimed |
| US-6331636-B1 | TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, DIABETES, HYPERTENSION, IMPOTENCY, APPETITE CONTROL | THE UPJOHN COMPANY | 2001-12-18 | — | — | US | disclosed |
| US-5545755-A | USEFUL TO TREAT CENTRAL NERVOUS SYSTEM DISORDERS, HYPERTENSION, DIABETES, SEXUAL IMPOTENCY AND TO CONTROL APPETITE | THE UPJOHN COMPANY (US) | 1996-08-13 | — | — | US | disclosed |
| EP-0476016-A1 | THERAPEUTICALLY USEFUL 2-AMINOTETRALIN DERIVATIVES | PHARMACIA & UPJOHN COMPANY (US) | 1992-03-25 | — | — | EP | disclosed |
| WO-1990015047-A1 | THERAPEUTICALLY USEFUL 2-AMINOTETRALIN DERIVATIVES | THE UPJOHN COMPANY (US) | 1990-12-13 | — | — | WO | disclosed |